ARCHIVES

Tivozanib Does Not Improve OS Compared to Sorafenib

This article is from The Cancer Letter archive.

Vol. 36 No. 2 | February 22, 2013

Download PDF Visit The Full Archive

Related Articles

New Mexico Program Covers Entire State

January 21, 1977

Why Did DeVita Resign MSK Post? Clash Of Style, Other Serious Issues Pointed To By Colleagues

June 7, 1991

Also in this 8-page issue: Dana-Farber opens center for advanced cancer science.

April 23, 2004

CMX001 Reduces Adenovirus Progression and Viremia

August 30, 2013

Lederle Scientists Report Powerful New Anticancer Agent

July 31, 1987

November issue of Business & Regulatory Report included.

November 28, 2003